USA
CSL plunges after CEO departure, weak earnings
CSL employees.
William West | AFP | Getty Images
Shares of Australian biotech firm C.S.L. It fell 17% on Wednesday after Chief Executive Paul McKenzie announced he would step down and posted weak earnings in the first half of the year.
Former chief executive Gordon Naylor will serve as interim CEO until a permanent replacement is found.
This is breaking news. Please check back for updates.
